Search
  • NEWS
  • STORIES
  • LIFESTYLE
  • TRENDING NEWS
Business Trends Today Business leaders news site
  • NEWS
  • STORIES
  • LIFESTYLE
  • TRENDING NEWS
Home Authors Posts by rogerjudd

rogerjudd

25882 POSTS 0 COMMENTS
AstraZeneca beats top-line and bottom-line estimates; reaffirms FY25 outlook
TOP STORIES

AstraZeneca beats top-line and bottom-line estimates; reaffirms FY25 outlook

rogerjudd -
July 29, 2025
0
Cadence to pay $140 million to U.S. for selling chip design tech to Chinese university
TOP STORIES

Cadence to pay $140 million to U.S. for selling chip design tech to Chinese university

rogerjudd -
July 29, 2025
0
Air Canada Non-GAAP EPS of C$0.60, revenue of C$5.63B; initiates Q3 and reaffirms FY25 outlook
TOP STORIES

Air Canada Non-GAAP EPS of C$0.60, revenue of C$5.63B; initiates Q3 and reaffirms FY25 outlook

rogerjudd -
July 29, 2025
0
Waymo plans to roll out robotaxi service in Dallas next year
TOP STORIES

Waymo plans to roll out robotaxi service in Dallas next year

rogerjudd -
July 29, 2025
0
Police officer among four dead in shooting at New York City office building
TOP TRENDS

Police officer among four dead in shooting at New York City office building

rogerjudd -
July 29, 2025
0
Bakkt dips after pricing $75M securities offering
TOP STORIES

Bakkt dips after pricing $75M securities offering

rogerjudd -
July 29, 2025
0
Nvidia ordered 300K H20 chips from Taiwan Semiconductor last week – report
TOP STORIES

Nvidia ordered 300K H20 chips from Taiwan Semiconductor last week – report

rogerjudd -
July 29, 2025
0
Kansas City Life Insurance declares $0.14 dividend
TOP STORIES

Kansas City Life Insurance declares $0.14 dividend

rogerjudd -
July 29, 2025
0
Woodward raises 2025 sales and EPS guidance with major Airbus A350 win and increased CapEx plans
TOP STORIES

Woodward raises 2025 sales and EPS guidance with major Airbus A350 win and increased CapEx plans

rogerjudd -
July 29, 2025
0
Exelixis outlines continued cabozantinib growth and zanzalintinib pipeline acceleration as new launches drive 19% revenue increase
TOP STORIES

Exelixis outlines continued cabozantinib growth and zanzalintinib pipeline acceleration as new launches drive 19% revenue increase

rogerjudd -
July 29, 2025
0
1...2,2852,2862,287...2,589Page 2,286 of 2,589
© Newspaper WordPress Theme by TagDiv